Total contact casting as part of an adaptive care approach: A case study

Ostomy Wound Management

Volumn 54, Issue 6, 2008, Pages 50-65

  Farid, Karen ^a   Farid, Mark ^b   Andrews, Claire M ^b  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Adaptational theory; Charcot foot; Total contact casting

Indexed keywords

ADAPTATION; AGED; ARTICLE; CASE REPORT; DIABETIC FOOT; FEMALE; FOOT MALFORMATION; HUMAN; PLASTER CAST; SCHIZOPHRENIA; THEORETICAL MODEL; WALKING DIFFICULTY; WOUND HEALING;

ADAPTATION, PHYSIOLOGICAL; AGED; CASTS, SURGICAL; DIABETIC FOOT; FEMALE; FOOT DEFORMITIES, ACQUIRED; HUMANS; MOBILITY LIMITATION; MODELS, THEORETICAL; SCHIZOPHRENIA; WOUND HEALING;

EID: 46349102703     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Roy C, Jones DA. Nursing Knowledge Development and Clinical Practice. New York, NY: Springer Publishing Co, Inc.;2007.
2. Warriner R, Burrell R. Infection and the chronic wound: a focus on silver. Adv Skin Wound Care. 2005;18(suppl 1):2-12.
3. Baker N, Green A, Krishnan S, Rayman G. Microvascular and c-fiber function in diabetic charcot neuroarthropathy and diabetic peripheral neuropathy. Diabetes Care. (2007);30(12):3077-3079.
4. Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy - is RANK-L the missing link? Diabetologia. 2004;47(9):1488-1492.
5. Frykberg RG, Mendeszoon E. Management of the diabetic Charcot foot. Diabetes Metab Res Rev. 2000;16(suppl 1):S559-S565.
6. Kayama C, Goto Y, Shimoya S, Hasegawa S, Murao S, Nakajo Y, Nibu K. Effects of gentian violet on refractory discharging ears infected with methicillin-resistant Staphylococcus aureus. J Otolaryngol. 2006;35(6):384-386.
7. Okano M, Noguchi S, Tabata K, Matsumoto Y. Topical gentian violet for cutaneous infection and nasal carriage with MRSA. Int J Dermatol. 2001;39(12):942-944.
8. Saji M, Taguchi S, Uchiyama K, Osono E, Hayama N, Ohkuni H. Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect. 1995;31(3):225-228.
9. Mak SS, Molassiotis A, Wan WM, Lee IY, Chan ES. The effects of hydrocolloid dressing and gentian violet on radiation-induced moist desquamation wound healing. Cancer Nurs. 2000;23(3):220-229.
10. Matricali GA, Deroo K, Dereymaeker G. Outcome and recurrence rate of diabetic foot ulcers treated by a total contact cast: short-term follow-up. Foot Ankle Int. 2003;24(9):680-684.
11. Bishop SM, Walker M, Rogers AA, Chen WY. Importance of moisture balance at the wound-dressing interface. J Wound Care. 2003;12(4):125-128.
12. Dyson M, Young S, Pendle CL. Comparison of the effects of moist and dry conditions on dermal repair. J Investig Dermatol. 1988;9(15):434-439.
13. Yin HQ, Langford R, Rurrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20(3):195-200.
14. Wright JB, Hansen DL, Burrell RE. The comparative efficacy of two antimicrobial barrier dressings: in-vitro examination of two controlled release of silver dressings. Wounds. 1998;10:179-188.
15. Monnier VM, Cerami A. Non-enzymatic glycosylation and browning of proteins in diabetes. Clin Endocrinol Metab. 1982;11(2):431-453.
16. Khoo CL. Identifying insulin resistance is important to prevent development of glucose intolerance and the metabolic syndrome. Med J Austr. 2007;186(5):269-270.
17. Andraws R, Brown DL. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). Am J Cardiol. 2007;99(7):1006-1012.
18. Liu K, Paterson AJ, Chin E, Kudlow JE. Glucose stimulates protein modification by O-linked GlNAc in pancreapancreatic beta cells: linkage of O-linked G1cNAc to beta cell death. Proc Natl Acad Sci USA. 2000;97(6):2820-2825.
19. Konrad RJ,Kudlow JE. The role of O-linked protein glycosylation in beta-cell dysfunction. Int J Mol Med. 2002;10(5):535-539.
20. Andrali SS, Qian Q, Ozcan S. Glucose mediates the translocation of NeuroD1 by O-linked glycosylation. J Biol Chem. 2007;282(21):15589-15596.
21. Ali T, Hasan M, Hamadani M, Harty RF. Gastroparesis. South Med J. 2007;100(3):281-286.
22. Smith DS, Ferris CD. Current concepts in diabetic gastroparesis. Drugs. 2003;63(13):1339-1358.
23. Armstrong DG, Lavery LA. Evidence-based options for off-loading diabetic wounds. Clin Podiatr Med Surg. 1998;15(1):95-104.
24. Lavery LA, Baranoski S, Ayello EA. Options for off-loading the diabetic foot. Adv Skin Wound Care. 2004;17(4 Pt 1):184-186.
25. Wu SC, Crews RT, Armstrong DG. The pivotal role of offloading in the management of neuropathic foot ulceration. Curr Diab Reports. 2005;5(6):423-429.
26. Inlow S,Kalla TP, Rahman J. Downloading plantar foot pressures in the diabetic patient. Ostomy Wound Manage. 1999;45(10):28-38.
27. Department of Health and Human Services/Health Resources and Services Administration. Bureau of Primary Health Care. National Hansen's Disease Programs. Available at: ask.hrsa.gov/orgdetail. Accessed April 23, 2007.
28. Sinacore DR. Total contact casting for diabetic neuropathic ulcers. Phys Ther. 1996;76(3):286-295.
29. Brand PW. The insensitive foot (including leprosy). In: Jahass MH, ed. Disorders of the Foot, Vol. 2. Philadelphia, Pa: W.B. Saunders Co;1982:1266-1286.
30. Sinacore DR, Mueller MJ. Total contact casting in the treatment of neuropathic ulcers. In: Levin ME,O'Neal LW, Bowker JH, eds. The Diabetic Foot, 5th ed. St. Louis, Mo: CV Mosby Year Book Inc;1993:285-304.
31. Birke JA, Novick A, Patout CA, Coleman WC. Healing rates of plantar ulcers in leprosy and diabetes. Leprosy Rev. 1992;63(4):365-374.
32. Nabuurs-Franssen MH, Sleegers R,Huijberts MS, et al.Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care. 2005;28(2):243-247.
33. Chipkin SR, Klugh SA, Chasan-Taber L. Exercise and diabetes. Cardiol Clin. 2001;19(3):489-505.
34. Wallberg-Hendriksson H, Rincon J, Zierath JR. Exercise in the management of non-insulin-dependent diabetes mellitus. Sports Med. 1998;25(1):25-35.
35. Oberbach A, Tonjes A, Kloting N, et al. Effect of a 4-week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol. 2006;154(4):577-585.
36. Nassis GP,Papantakou K, Skenderi K, et al.Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls.Metabolism. 2005;54(11):1472-1479.
37. O'Leary VB,Marchetti CM,Krishnan RK, Stetzer BP,Gonzalez F, Kirwan JP. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol. 2006;100(5):1584-1589.
38. Ryan AS. Insulin resistance with aging: effects of diet and exercise. Sports Med. 2000;30(5):327-346.
39. Willey KA, Singh MA. Battling insulin resistance in elderly obese people with type 2 diabetes: bring on the heavy weights.Diabetes Care. 2003;26 (5):1580-1588.
40. American Diabetes Association. Position statement. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care. 1999;22(suppl 1):S42-S48.
41. Dominguez LJ, Barbagallo M, Moro L. Collagen overglycosylation: a biochemical feature that may contribute to bone quality. Biochem Biophys Res Comm. 2005;330(1):1-4.
42. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4-8.
43. Hough S, Fausto A, Sonn Y, Dong Jo OK, Birge SJ, Avioli LV. Vitamin D metabolism in the chronic streptozotocin-induced diabetic rat. Endocrinology. 1983;113(2):790-796.
44. Patel SR, Xu Y, Koenig RJ,Hsu CH. Effect of glucose on the function of the calcitriol receptor and vitamin D metabolism. Kidney Internals. 1997;52(1):79-86.
45. Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol. 2006;248(1-2):149-159.
46. Inouye K, Sakaki T. Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24- hydroxylase (CYP24). Biotechnol Ann Rev. 2001;7:179-194.
47. Xue Y,Karaplis AC,Hendy GN, Goltzman D,Miao D. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alphahydroxylase and parathyroid hormone null alleles. Endocrinology. 2006;147(10):4801-4810.
48. van Driel M, Koedam M, Buurman DJ, et al. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J. 2006;20(13):2417-2419.
49. Robinet A, Alouane L,Hoizey G,Millart H.Advanced-glycation end products (AGEs) derived from glycated albumin suppress early beta1-adrenergic preconditioning. Fundam Clin Pharmacol. 2007;21(1):35-43.
50. Gawronska-Szklarz B, Gornik W, Pawlik A, et al. N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances. Eur J Clin Pharmacol. 1997;51(6):431-435.
51. Nishikawa T, Kukidome D, Sonoda K, et al. Impact of mitochondrial ROS production on diabetic vascular complications. Diab Res Clin Pract. 2007;77(suppl 1):S161-S164.
52. Meerwaldt R, Lutgers HL, Links TP, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care. 2007;30(1):107-112.
53. Tajaddini A, Scoffone HM, Botek G, Davis BL. Laser-induced auto-fluorescence (LIAF) as a method for assessing skin stiffness preceding diabetic ulcer formation. J Biomechanics. 2007;40(4):736-741.
54. Murray HJ,Young MJ,Hollis S, Boulton AJ. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med. 1996;13(11):979-982.
55. Giurato L, Uccioli L. The diabetic foot: Charcot joint and osteomyelitis. Nucl Med Comm. 2006;27(9):745-749.
56. Gandhi A, Liporace F, Azad V, MattieJ, Lin SS. Diabetic fracture healing. Foot Ankle Clin. 2006;11(4):805-824.
57. Chantelau E, Richter A, Ghassem-Zadeh N, Poll LW. "Silent"bone stress injuries in the feet of diabetic patients with polyneuropathy: a report on 12 cases. Arch Orthop Trauma Surg. 2007;127(3):171-177.
58. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care. 1999;22(7):1029-1035.
59. Brem H, Jacobs T, Vileikyte L, et al. Wound-healing protocols for diabetic foot and pressure ulcers. Surg Technol Intern. 2003;11:85-92.
60. Strine TW, Okoro CA, Chapman DP, Beckles GL, Balluz L,Mokdad AH. The impact of formal diabetes education on the preventive health practices and behaviors of persons with type 2 diabetes. Prev Med. 2005;41(1):79-84.
61. Pinzur MS, Slovenkai MP, Trepman E, Shields NN; Diabetes Committee of American Orthopaedic Foot and Ankle Society. Guidelines for diabetic foot care: recommendations endorsed by the Diabetes Committee of the American Orthopaedic Foot and Ankle Society. Foot Ankle Intern. 2005;26(1):113-119.
62. Eskelinen E, Eskelinen A, Alback A, Lepantalo M. Major amputation incidence decreases both in non-diabetic and in diabetic patients in Helsinki. Scand J Surg. 2006;95(3):185-189.